Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
Yuriko Ishida, Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Takashi Ogura
Source: ERJ Open Res, 8 (4) 00337-2022; 10.1183/23120541.00337-2022
  
For technical reasons, this interactive material needs to open in a new window.
Please allow pop-ups from ers-education.org.
If the window did not open automatically, please click here.
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yuriko Ishida, Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Takashi Ogura. Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation. ERJ Open Res, 8 (4) 00337-2022; 10.1183/23120541.00337-2022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|